Cancer neovasculature-targeted NIR-PIT, targeting VEGFR-2, for instance, showed anti-cancer effects in xenograft mouse models of gastric cancer [156] Cancer neovasculature-targeted NIR-PIT is a viable strategy for treating ccRCC. This evidence concerns the gene KDR and nonpapillary renal cell carcinoma.